Back
ACADIA Pharmaceuticals Vs. Amylyx Pharmaceuticals Industry Stock Comparison
Sell
31
ACAD
ACADIA Pharmaceuticals
Last Price:
15.02
Seasonality Move:
7.19%
Sell
27
AMLX
Amylyx Pharmaceuticals
Last Price:
1.83
Seasonality Move:
87.32%
Sell
31
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $15.10. The Score for ACAD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy, Sell or Hold?
- The current Amylyx Pharmaceuticals [AMLX] share price is $1.84. The Score for AMLX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- AMLX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $15.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMLX Stock Price Chart
What is Amylyx Pharmaceuticals's stock price today?
-
The Amylyx Pharmaceuticals share price today is $1.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing slight selling pressure.
ACAD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.83 | Sell |
Relative Strength Index (14 RSI): | 32.73 | Sell |
Chaikin Money Flow: | 1207626 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.42 - 17.24) | Sell |
Bollinger Bands (100): | (16.99 - 27.21) | Sell |
AMLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.41 | Sell |
Relative Strength Index (14 RSI): | 30.23 | Sell |
Chaikin Money Flow: | -581732 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.82 - 1.98) | Sell |
Bollinger Bands (100): | (2.15 - 16.19) | Sell |
ACAD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.05 | Buy |
20-day SMA: | 16.15 | Sell |
50-day SMA: | 17.4 | Sell |
200-day SMA: | 23.39 | Sell |
8-day EMA: | 15.27 | Sell |
20-day EMA: | 16.02 | Sell |
50-day EMA: | 17.88 | Sell |
200-day EMA: | 21.75 | Sell |
AMLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.83 | Buy |
20-day SMA: | 1.88 | Sell |
50-day SMA: | 2.35 | Sell |
200-day SMA: | 13.29 | Sell |
8-day EMA: | 1.85 | Sell |
20-day EMA: | 2.02 | Sell |
50-day EMA: | 4 | Sell |
200-day EMA: | 12.28 | Sell |
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.02 per share, an increase this year of $0.88 per share, and an increase next year of $0.53 per share.
Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.01 per share, an increase next quarter of $0.14 per share, a decrease this year of $2.19 per share, and a decrease next year of $0.28 per share.
ACADIA Pharmaceuticals Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Amylyx Pharmaceuticals Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |